Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
Character recognition device and a method therefor










Image Number 4 for United States Patent #7233697.

The present invention relates to an optical character recognition device (OCR) for reading a form provided with character frames in reading fields, into which a user fills each character. Characteristic vectors are extracted from the character images of each frame. A number of characters decision unit 16, into which the characteristic vectors are input, decides the number of characters filled in one of the character frames. A character separation unit 18 separates each of characters from the character image based on the number of characters decided by the decision unit 16. The character recognition unit 20 then recognizes each of the character. The OCR according o the present invention is able to read the form correctly, in which a plurality of characters are filled in one of the frames.








 
 
  Recently Added Patents
Processing circuitry for use with a position sensor
Resolution setting apparatus, resolution setting method, and recording medium recording a resolution setting program when a television is used as a monitor of a computer
Jewelry
Adaptive non-positive inductor current detector (ANPICD)
Method for driving electrophoretic display device, electrophoretic display device, and electronic device
Clusterin antisense therapy for treatment of cancer
Sparse network almanac
  Randomly Featured Patents
Modifying an estimate value
Semi-permeable membranes derived from reactive oligomers
Substituted pyrazolo[3,4-d]pyrimidines as ACK-1 and LCK inhibitors
Process for the non-oxidative preparation of formaldehyde from methanol
Epothilone compounds and methods for making the same
Fluorescent screen forming method, fluorescent screen forming apparatus and cathode-ray tube
Condensate purification process by use of dilute clear lime solution
Winged practice ball
Adhesive for bonding to low surface energy surfaces
Compositions and methods of reducing side effects and toxicity of methotrexate when given as orotate derivatives